Lv5
1594 积分 2023-12-04 加入
Evaluation of clinical prediction models (part 2): how to undertake an external validation study
2小时前
待确认
Developing clinical prediction models: a step-by-step guide
2小时前
待确认
A head-to-head comparison of sextant-systematic biopsy vs. extended-systematic biopsy for prostate cancer diagnosis in the era of MRI-targeted biopsy: SEXTANT-PRO non-inferiority randomized clinical trial
19小时前
求助中
Comparison of Whole‐Gland and Transition Zone PSA Density in Predicting Clinically Significant Prostate Cancer in PI‐RADS 3 Lesions
2天前
已完结
The risk prediction model for acute urine retention after perineal prostate biopsy based on the LASSO approach and Boruta feature selection
3天前
已完结
Ultrasound echogenicity is complementary to PI-RADS for risk stratification of clinically significant prostate cancer
6天前
已完结
PSA Density and Lesion Volume: Key Factors in Avoiding Unnecessary Biopsies for PI‐RADS 3 Lesions
6天前
已完结
Optimizing biopsy decisions in PI-RADS 3 lesions: cross-institutional validation of a local clinical risk model
6天前
已完结
PI-RADS 3 lesions: Does the association of the lesion volume with the prostate-specific antigen density matter in the diagnosis of clinically significant prostate cancer?
7天前
已完结
Diagnostic and Clinical Impact of Imaging Modality on PSA Density: TRUS Versus MRI in Gray-Zone Prostate Cancer
7天前
已完结
皖公网安备34019202002308
